SOHM Announces Business Outlook for 2024
05 déc. 2023 09h30 HE
|
SOHM, Inc.
CHINO HILLS, Calif., Dec. 05, 2023 (GLOBE NEWSWIRE) -- via IBN -- SOHM, Inc. (OTC PINK: SHMN) (the “Company”), a pharmaceutical, nutraceutical and cosmeceutical Company that manufactures and markets...
SOHM Announces New CDMO GMP Manufacturing Facility in Carlsbad, California
21 nov. 2023 09h30 HE
|
SOHM, Inc.
CHINO HILLS, Calif., Nov. 21, 2023 (GLOBE NEWSWIRE) -- via IBN -- SOHM, Inc. (OTC PINK: SHMN), a pharmaceutical, nutraceutical and cosmeceutical company that manufactures and markets generic drugs...
SOHM, Inc. Announces the Appointment of Wm. Dewey Rushing as VP of Quality with Immediate Effect
11 sept. 2023 09h45 HE
|
SOHM, Inc.
CHINO HILLS, Calif., Sept. 11, 2023 (GLOBE NEWSWIRE) -- via IBN -- SOHM, Inc. (OTC PINK: SHMN), a pharmaceutical, nutraceutical and cosmeceutical company that manufactures and markets generic drugs...
SOHM, Inc. Expands Its Advisory Board, Appointing Dr. Krishna Bhat, M.D, Ph.D., FACC, as Chief Medical Advisor
24 août 2023 06h30 HE
|
SOHM, Inc.
CHINO HILLS, Calif., Aug. 24, 2023 (GLOBE NEWSWIRE) -- via IBN -- SOHM, Inc. (OTC PINK: SHMN), a pharmaceutical, nutraceutical and cosmeceutical company that manufactures and markets generic drugs...
Alvogen CEO Robert Wessman speaks exclusively to World Finance about new opportunities in generic pharmaceuticals
22 janv. 2018 05h04 HE
|
World Finance
LONDON, Jan. 22, 2018 (GLOBE NEWSWIRE) -- Industry disruptor Robert Wessman, the CEO of rapidly growing generic pharmaceuticals company Alvogen, shares his thoughts on the latest market trends in...
A man on a mission to transform generic pharmaceuticals: Alvogen CEO and founder, Robert Wessman, discusses the company’s growth
04 janv. 2018 06h16 HE
|
World Finance
LONDON, Jan. 04, 2018 (GLOBE NEWSWIRE) -- The pharmaceuticals industry is going through one of its most exciting periods yet. Generic pharmaceuticals have taken off, leading to much more innovation...
Signet Healthcare Partners Closes $137.2 Million Life Science Fund
11 janv. 2017 17h52 HE
|
Signet Healthcare Partners
NEW YORK, Jan. 11, 2017 (GLOBE NEWSWIRE) -- Signet Healthcare Partners (“Signet”), a private equity fund that provides growth capital to commercial Life Sciences companies, is pleased to announce...
InnoPharma Inc. Announces Launch of Generic Cidofovir Injection in the United States
08 mars 2013 08h00 HE
|
InnoPharma, Inc
PISCATAWAY, NJ, March 8, 2013 (GLOBE NEWSWIRE) -- InnoPharma, Inc.
today announced the launch of cidofovir injection (generic
equivalent of Vistide®) in 5mL single-use vials. ...